Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/3814
Title: DIFFICULT ASPECTS OF TREATMENTS PATIENTS WITH ACUTE LUNG ABSCESSES WHO SURVIVED COVID -19
Authors: Atakov S.S., Okhunov A.O., Bobokulova Sh.A., Kasimov U.K., Bobabekov A.R.
Keywords: : acute lung abscesses, lung gangrene, diagnostics, microbiology, sparing methods of treatment
Issue Date: 2022
Publisher: Toshkent tibbiyot akademiyasi - O'quv va ilmiy tibbiyot jurnali
Abstract: Suppurative diseases of the lungs are topical issues of pulmonology that require detailed study due to the difficulties of diagnosis and high mortality of patients. This is due to a number of objective and subjective reasons, in particular, such as the widespread use of antibiotic- resistant microflora, which is especially important when antibiotics are prescribed unreasonably, even with a mild form of COVID -19. This, of course, affects COVID patients, who already have reduced immunity. The question of the exact mechanism of development of purulent complications of the lungs after or during infection with COVID -19 remains open. Clinical and radiological signs of a lung abscess often resemble the symptoms of pneumonia, however, antibacterial and symptomatic therapy have differences. With gangrene of the lung, the increase in intoxication syndrome can be gradual, which reduces the doctor's alertness regarding the most severe disease and causes inade- quate therapy. Comprehensive diagnostic measures, knowledge of the main clinical, instrumental and laboratory parameters are necessary for all physicians.
URI: http://repository.tma.uz/xmlui/handle/1/3814
ISSN: 2181-3175
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
3. Difficult aspects of treatments patients with acute lung abscesses who survived covid -19.pdfDIFFICULT ASPECTS OF TREATMENTS PATIENTS WITH ACUTE LUNG ABSCESSES WHO SURVIVED COVID -19462.25 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.